Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.68 USD | +1.38% | -4.42% | -35.78% |
05/04 | Sector Update: Health Care Stocks Lean Higher Pre-Bell Friday | MT |
04/04 | Caribou Gets FDA Clearance For Phase 1 Testing of CB-010 Cell Therapy in Lupus Patients | MT |
Business Summary
Number of employees: 158
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Allogeneic CAR-T and CAR-NK Cell Therapies
100.0
%
| 14 | 100.0 % | 34 | 100.0 % | +148.91% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
95.0
%
| 13 | 96.0 % | 33 | 95.0 % | +146.34% |
Rest of World
5.0
%
| 1 | 4.0 % | 2 | 5.0 % | +211.50% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rachel Haurwitz
FOU | Founder | 38 | 28/11/28 |
Jason O’Byrne
DFI | Director of Finance/CFO | 54 | 09/21/09 |
Steven Kanner
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/17/01 |
Timothy Kelly
CTO | Chief Tech/Sci/R&D Officer | 55 | 07/01 |
Reigin Zawadzki
HRO | Human Resources Officer | - | 27/23/27 |
Cindy Hayashi
HRO | Human Resources Officer | - | 01/16/01 |
Ryan Fischesser
AUD | Comptroller/Controller/Auditor | - | - |
Elaine Alambra
LAW | General Counsel | - | - |
Ruhi Khan
PRN | Corporate Officer/Principal | - | 08/21/08 |
Barbara McClung
LAW | General Counsel | 69 | 01/15/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 01/21/01 | |
Scott Braunstein
BRD | Director/Board Member | 60 | 01/21/01 |
Director/Board Member | 59 | 08/21/08 | |
Rachel Haurwitz
FOU | Founder | 38 | 28/11/28 |
Natalie Sacks
BRD | Director/Board Member | 59 | 01/18/01 |
David Johnson
BRD | Director/Board Member | 55 | 11/22/11 |
Ran Zheng
BRD | Director/Board Member | 60 | 24/21/24 |
Nancy Whiting
BRD | Director/Board Member | 51 | 24/21/24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,317,771 | 81,157,193 ( 89.86 %) | 0 | 89.86 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.78% | 328M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- CRBU Stock
- Company Caribou Biosciences, Inc.